Nova Eye Medical Limited (EYE.AX)
AUD 0.11
(1.82%)
AUD 0.11
(1.82%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 23.32 Million AUD | 37.0% |
| 2023 | 17.02 Million AUD | 27.26% |
| 2022 | 13.37 Million AUD | -0.12% |
| 2021 | 13.39 Million AUD | 4.89% |
| 2020 | 12.76 Million AUD | -20.89% |
| 2019 | 16.14 Million AUD | -79.68% |
| 2018 | 79.43 Million AUD | 10.61% |
| 2017 | 71.8 Million AUD | -1.65% |
| 2016 | 73.01 Million AUD | 16.34% |
| 2015 | 62.76 Million AUD | 15.41% |
| 2014 | 54.37 Million AUD | 26.23% |
| 2013 | 43.07 Million AUD | -9.31% |
| 2012 | 47.5 Million AUD | 10.19% |
| 2011 | 43.11 Million AUD | -11.21% |
| 2010 | 48.55 Million AUD | -18.06% |
| 2009 | 59.25 Million AUD | 15.77% |
| 2008 | 51.18 Million AUD | 12.48% |
| 2007 | 45.5 Million AUD | 31.16% |
| 2006 | 34.69 Million AUD | 28.78% |
| 2005 | 26.93 Million AUD | 9.22% |
| 2004 | 24.66 Million AUD | -4.95% |
| 2003 | 25.95 Million AUD | -5.13% |
| 2002 | 27.35 Million AUD | 17096150.0% |
| 2001 | 160.00 AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | -100.0% |
| 1997 | 102 Thousand AUD | 1253.86% |
| 1996 | 7534.00 AUD | 7.63% |
| 1995 | 7000.00 AUD | -94.02% |
| 1994 | 117 Thousand AUD | 48.1% |
| 1993 | 79 Thousand AUD | -55.62% |
| 1992 | 178 Thousand AUD | -47.18% |
| 1991 | 337 Thousand AUD | -52.4% |
| 1990 | 708 Thousand AUD | -37.51% |
| 1989 | 1.13 Million AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 13.18 Million AUD | 0.0% |
| 2024 FY | 23.32 Million AUD | 37.0% |
| 2024 Q2 | 10.13 Million AUD | 0.0% |
| 2023 Q2 | 8.39 Million AUD | 0.0% |
| 2023 Q4 | 8.63 Million AUD | 0.0% |
| 2023 FY | 17.02 Million AUD | 27.26% |
| 2022 Q2 | 6.54 Million AUD | 0.0% |
| 2022 FY | 13.37 Million AUD | -0.12% |
| 2022 Q4 | 6.83 Million AUD | 0.0% |
| 2021 FY | 13.39 Million AUD | 4.89% |
| 2021 Q4 | 6.75 Million AUD | 0.0% |
| 2021 Q2 | 6.64 Million AUD | 0.0% |
| 2020 FY | 12.76 Million AUD | -20.89% |
| 2020 Q2 | 7.42 Million AUD | 0.0% |
| 2020 Q4 | 5.34 Million AUD | 0.0% |
| 2019 Q2 | 7.71 Million AUD | 0.0% |
| 2019 Q4 | 40 Million AUD | 0.0% |
| 2019 FY | 16.14 Million AUD | -79.68% |
| 2018 Q4 | 41.18 Million AUD | 0.0% |
| 2018 FY | 79.43 Million AUD | 10.61% |
| 2018 Q2 | 38.24 Million AUD | 0.0% |
| 2017 Q4 | 36.87 Million AUD | 0.0% |
| 2017 Q2 | 34.93 Million AUD | 0.0% |
| 2017 FY | 71.8 Million AUD | -1.65% |
| 2016 FY | 73.01 Million AUD | 16.34% |
| 2016 Q2 | 35.08 Million AUD | 0.0% |
| 2016 Q4 | 37.93 Million AUD | 0.0% |
| 2015 Q2 | 30.72 Million AUD | 0.0% |
| 2015 Q4 | 32.03 Million AUD | 0.0% |
| 2015 FY | 62.76 Million AUD | 15.41% |
| 2014 FY | 54.37 Million AUD | 26.23% |
| 2014 Q2 | 25.88 Million AUD | 0.0% |
| 2014 Q4 | 28.49 Million AUD | 0.0% |
| 2013 Q4 | 20.94 Million AUD | 0.0% |
| 2013 Q2 | 22.13 Million AUD | 0.0% |
| 2013 FY | 43.07 Million AUD | -9.31% |
| 2012 FY | 47.5 Million AUD | 10.19% |
| 2012 Q4 | 11.87 Million AUD | 0.0% |
| 2012 Q3 | 11.87 Million AUD | 0.0% |
| 2012 Q1 | 10.84 Million AUD | 0.0% |
| 2012 Q2 | 11.87 Million AUD | 9.52% |
| 2011 Q2 | 10.84 Million AUD | -10.67% |
| 2011 Q1 | 12.13 Million AUD | 0.0% |
| 2011 FY | 43.11 Million AUD | -11.21% |
| 2011 Q4 | 10.84 Million AUD | 0.0% |
| 2011 Q3 | 10.84 Million AUD | 0.0% |
| 2010 Q4 | 12.13 Million AUD | 0.0% |
| 2010 Q3 | 12.13 Million AUD | 0.0% |
| 2010 Q2 | 12.13 Million AUD | -18.06% |
| 2010 FY | 48.55 Million AUD | -18.06% |
| 2010 Q1 | 14.81 Million AUD | 0.0% |
| 2009 Q3 | 14.81 Million AUD | 0.0% |
| 2009 Q2 | 14.81 Million AUD | 15.77% |
| 2009 FY | 59.25 Million AUD | 15.77% |
| 2009 Q1 | 12.79 Million AUD | 0.0% |
| 2009 Q4 | 14.81 Million AUD | 0.0% |
| 2008 Q1 | 11.37 Million AUD | 0.0% |
| 2008 Q3 | 12.79 Million AUD | 0.0% |
| 2008 FY | 51.18 Million AUD | 12.48% |
| 2008 Q4 | 12.79 Million AUD | 0.0% |
| 2008 Q2 | 12.79 Million AUD | 12.48% |
| 2007 Q2 | 11.37 Million AUD | 31.16% |
| 2007 FY | 45.5 Million AUD | 31.16% |
| 2007 Q4 | 11.37 Million AUD | 0.0% |
| 2007 Q3 | 11.37 Million AUD | 0.0% |
| 2007 Q1 | 8.67 Million AUD | 0.0% |
| 2006 Q2 | 8.67 Million AUD | 22.36% |
| 2006 FY | 34.69 Million AUD | 28.78% |
| 2006 Q1 | 7.08 Million AUD | 0.0% |
| 2006 Q4 | 8.67 Million AUD | 0.0% |
| 2006 Q3 | 8.67 Million AUD | 0.0% |
| 2005 Q1 | 6.16 Million AUD | 0.0% |
| 2005 Q2 | 7.08 Million AUD | 14.94% |
| 2005 Q3 | 7.08 Million AUD | 0.0% |
| 2005 Q4 | 7.08 Million AUD | 0.0% |
| 2005 FY | 26.93 Million AUD | 9.22% |
| 2004 Q2 | 6.16 Million AUD | -5.36% |
| 2004 FY | 24.66 Million AUD | -4.95% |
| 2004 Q4 | 6.16 Million AUD | 0.0% |
| 2004 Q3 | 6.16 Million AUD | 0.0% |
| 2004 Q1 | 6.51 Million AUD | 0.0% |
| 2003 Q1 | 6.83 Million AUD | 0.0% |
| 2003 FY | 25.95 Million AUD | -5.13% |
| 2003 Q2 | 6.51 Million AUD | -4.72% |
| 2003 Q3 | 6.51 Million AUD | 0.0% |
| 2003 Q4 | 6.51 Million AUD | 0.0% |
| 2002 FY | 27.35 Million AUD | 17096150.0% |
| 2002 Q3 | 6.83 Million AUD | 0.0% |
| 2002 Q4 | 6.83 Million AUD | 0.0% |
| 2002 Q1 | 40.00 AUD | 0.0% |
| 2002 Q2 | 6.83 Million AUD | 17096150.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q3 | 40.00 AUD | 0.0% |
| 2001 Q4 | 40.00 AUD | 0.0% |
| 2001 Q2 | 40.00 AUD | 0.0% |
| 2001 FY | 160.00 AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1998 Q1 | 25.5 Thousand AUD | 0.0% |
| 1998 FY | - AUD | -100.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | -100.0% |
| 1997 Q1 | 1883.50 AUD | 0.0% |
| 1997 Q2 | 25.5 Thousand AUD | 1253.86% |
| 1997 Q3 | 25.5 Thousand AUD | 0.0% |
| 1997 FY | 102 Thousand AUD | 1253.86% |
| 1997 Q4 | 25.5 Thousand AUD | 0.0% |
| 1996 FY | 7534.00 AUD | 7.63% |
| 1996 Q3 | 1883.50 AUD | 0.0% |
| 1996 Q1 | 1750.00 AUD | 0.0% |
| 1996 Q2 | 1883.50 AUD | 7.63% |
| 1996 Q4 | 1883.50 AUD | 0.0% |
| 1995 Q3 | 1750.00 AUD | 0.0% |
| 1995 Q2 | 1750.00 AUD | -94.02% |
| 1995 Q1 | 29.25 Thousand AUD | 0.0% |
| 1995 FY | 7000.00 AUD | -94.02% |
| 1995 Q4 | 1750.00 AUD | 0.0% |
| 1994 FY | 117 Thousand AUD | 48.1% |
| 1994 Q3 | 29.25 Thousand AUD | 0.0% |
| 1994 Q2 | 29.25 Thousand AUD | 48.1% |
| 1994 Q1 | 19.75 Thousand AUD | 0.0% |
| 1994 Q4 | 29.25 Thousand AUD | 0.0% |
| 1993 Q2 | 19.75 Thousand AUD | -55.62% |
| 1993 Q4 | 19.75 Thousand AUD | 0.0% |
| 1993 Q3 | 19.75 Thousand AUD | 0.0% |
| 1993 FY | 79 Thousand AUD | -55.62% |
| 1993 Q1 | 44.5 Thousand AUD | 0.0% |
| 1992 Q1 | 84.25 Thousand AUD | 0.0% |
| 1992 Q4 | 44.5 Thousand AUD | 0.0% |
| 1992 Q2 | 44.5 Thousand AUD | -47.18% |
| 1992 Q3 | 44.5 Thousand AUD | 0.0% |
| 1992 FY | 178 Thousand AUD | -47.18% |
| 1991 Q4 | 84.25 Thousand AUD | 0.0% |
| 1991 Q3 | 84.25 Thousand AUD | 0.0% |
| 1991 Q1 | 177 Thousand AUD | 0.0% |
| 1991 Q2 | 84.25 Thousand AUD | -52.4% |
| 1991 FY | 337 Thousand AUD | -52.4% |
| 1990 Q4 | 177 Thousand AUD | 0.0% |
| 1990 Q3 | 177 Thousand AUD | 0.0% |
| 1990 Q1 | 283.25 Thousand AUD | 0.0% |
| 1990 FY | 708 Thousand AUD | -37.51% |
| 1990 Q2 | 177 Thousand AUD | -37.51% |
| 1989 Q2 | 283.25 Thousand AUD | 0.0% |
| 1989 Q3 | 283.25 Thousand AUD | 0.0% |
| 1989 Q4 | 283.25 Thousand AUD | 0.0% |
| 1989 FY | 1.13 Million AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -521.295% |
| Adherium Limited | 840.98 Thousand AUD | -2673.543% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 63.185% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -470.777% |
| Anteris Technologies Ltd | 4.11 Million AUD | -467.369% |
| Control Bionics Limited | 5.12 Million AUD | -354.954% |
| CardieX Limited | 10.9 Million AUD | -113.88% |
| Compumedics Limited | 49.71 Million AUD | 53.086% |
| Cochlear Limited | 2.25 Billion AUD | 98.967% |
| CleanSpace Holdings Limited | 15.72 Million AUD | -48.362% |
| Cyclopharm Limited | 27.13 Million AUD | 14.055% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | -107.902% |
| HeraMED Limited | 402.89 Thousand AUD | -5689.321% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -3689.183% |
| ImpediMed Limited | 10.31 Million AUD | -126.039% |
| InhaleRx Limited | 1.2 Million AUD | -1837.218% |
| LBT Innovations Limited | 1.25 Million AUD | -1757.086% |
| Micro-X Limited | 15.22 Million AUD | -53.232% |
| Neurotech International Limited | 1963.00 AUD | -1188132.298% |
| OncoSil Medical Limited | 1.56 Million AUD | -1390.051% |
| PolyNovo Limited | 103.19 Million AUD | 77.397% |
| Respiri Limited | 456.91 Thousand AUD | -5004.899% |
| SomnoMed Limited | 91.65 Million AUD | 74.55% |
| Universal Biosensors, Inc. | 6.63 Million AUD | -251.659% |
| Uscom Limited | 3.72 Million AUD | -525.865% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | -169.031% |